Dyne Therapeutics, Inc. (DYN)
17.90
+1.09
(+6.48%)
USD |
NASDAQ |
Jun 09, 16:00
17.90
0.00 (0.00%)
After-Hours: 20:00
Dyne Therapeutics EPS Diluted (Quarterly) : -0.7323 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Vor Biopharma, Inc. | -5.105 |
| BioCryst Pharmaceuticals, Inc. | -2.980 |
| Agenus, Inc. | 1.023 |
| Amgen, Inc. | 3.344 |
| Imunon, Inc. | -0.8449 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -120.85M |
| Total Expenses (Quarterly) | 120.85M |
| Enterprise Value | 1.980B |
| Earnings Yield | -18.02% |
| Normalized Earnings Yield | -18.02 |